<unk>  is a Factor Xa reversal agent that is FDA approved for the {{{indicationType}}} of<unk> , coagulation factor Xa (recombinant), inactivated-zhzo is a recombinant modified human Factor Xa (FXa) protein indicated for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include urinary tract infections, pneumonia, infusion-related reactions.
ANDEXXA
DAMGO
CHHIP
PLATO
ELSI
ALARA
EVAR
ITRAQ